Effectiveness of a novel serotonin blocker, sarpogrelate, for patients with angina pectoris.
about
The antidepressant 5-HT2A receptor antagonists pizotifen and cyproheptadine inhibit serotonin-enhanced platelet functionThe role of 5-HT on the cardiovascular and renal systems and the clinical potential of 5-HT modulation.Sarpogrelate: cardiovascular and renal clinical potential.Efficacy of metabolic modulators in ischemic heart disease: an overview.Effect of the potent CYP2D6 inhibitor sarpogrelate on the pharmacokinetics and pharmacodynamics of metoprolol in healthy male Korean volunteers.
P2860
Effectiveness of a novel serotonin blocker, sarpogrelate, for patients with angina pectoris.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Effectiveness of a novel serot ...... patients with angina pectoris.
@ast
Effectiveness of a novel serot ...... patients with angina pectoris.
@en
Effectiveness of a novel serot ...... patients with angina pectoris.
@nl
type
label
Effectiveness of a novel serot ...... patients with angina pectoris.
@ast
Effectiveness of a novel serot ...... patients with angina pectoris.
@en
Effectiveness of a novel serot ...... patients with angina pectoris.
@nl
prefLabel
Effectiveness of a novel serot ...... patients with angina pectoris.
@ast
Effectiveness of a novel serot ...... patients with angina pectoris.
@en
Effectiveness of a novel serot ...... patients with angina pectoris.
@nl
P2093
P356
P1476
Effectiveness of a novel serot ...... patients with angina pectoris.
@en
P2093
Hiroyuki Hanada
Hitoshi Nakajima
Jong-Dae Lee
Masatoshi Fujita
Shoichi Miyamoto
Toru Kinugawa
P356
10.1067/MHJ.2002.124056
P407
P577
2002-08-01T00:00:00Z